Found: 14
Select item for more details and to access through your institution.
Improvements in Glycemic Control Achieved by Altering the tmax Setting in the iLet® Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 7, p. 2019, doi. 10.1007/s13300-021-01087-x
- By:
- Publication type:
- Article
Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis– Related Diabetes.
- Published in:
- Diabetes Care, 2024, v. 47, n. 1, p. 101, doi. 10.2337/dc23-1411
- By:
- Publication type:
- Article
The Bihormonal Bionic Pancreas Improves Glycemic Control in Individuals With Hyperinsulinism and Postpancreatectomy Diabetes: A Pilot Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.
- Published in:
- 2021
- By:
- Publication type:
- Letter
216-OR: A Random-Order, Double-Blinded, Placebo-Controlled Study of the Bionic Pancreas in the Bihormonal vs. Insulin-Only Configurations Using Two Different Glucose Targets in Adults with Type 1 Diabetes in the Home-Use Setting.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-216-OR
- By:
- Publication type:
- Article
691-P: Closed-Loop Glycemic Control with the Insulin-Only Bionic Pancreas for the Management of Type 2 Diabetes.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-691-P
- By:
- Publication type:
- Article
98-LB: Individual Glycemic Response to Ultra-Rapid vs. Rapid Insulin Delivered Automatically with the Ilet Bionic Pancreas System.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-98-LB
- By:
- Publication type:
- Article
200-OR: Effects of Glucose Target on the Performance of a Bihormonal Bionic Pancreas.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-200-OR
- By:
- Publication type:
- Article
198-OR: Individual Response of Automated Glycemic Control with the iLet Bionic Pancreas in the Insulin-Only vs. Bihormonal Configuration with the Stable Glucagon Analog Dasiglucagon.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-198-OR
- By:
- Publication type:
- Article
103-LB: Individual Glycemic Response to Faster Aspart Delivered by the Ilet Bionic Pancreas with Non-default vs. Default Tmax Settings.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-103-LB
- By:
- Publication type:
- Article
77-OR: First Human Study Testing the iLet, a Purpose-Built Bionic Pancreas Platform.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-77-OR
- By:
- Publication type:
- Article
1077-P: Treatment of Post-pancreatectomy Diabetes in Individuals with Congenital Hyperinsulinism Using a Bihormonal Bionic Pancreas.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1077-P
- By:
- Publication type:
- Article
1063-P: First Test of the iLet, a Purpose-Built Bionic Pancreas Platform, in Children and Adolescents with Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1063-P
- By:
- Publication type:
- Article
1053-P: Automated Adaptation of the Bionic Pancreas while Transitioning from Multiple Daily Injection Insulin Regimens.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1053-P
- By:
- Publication type:
- Article